-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – RSC-1255 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RSC-1255 in Solid Tumor Drug Details: RSC-1255 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – SLN-124 in Alpha Thalassaemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.SLN-124 in Alpha ThalassaemiaDrug Details: SLN-124 is under development for the treatment of hereditary hemochromatosis, alpha/beta...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Simurosertib in Metastatic Colorectal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Simurosertib in Metastatic Colorectal Cancer Drug Details:TAK-931 is under development for the treatment of advanced non-hematologic...
-
Product Insights
![]()
TAZIZ Ruwais Complex, United Arab Emirates
TAZIZ Ruwais Complex is located in Abu Dhabi, United Arab Emirates. The petrochemicals complex is owned by Reliance Industries Ltd (50%); Abu Dhabi National Oil Co (30.00. It will be operated by Abu Dhabi Chemicals Derivatives Co RSC Ltd. The project is currently in the announced stage and is expected to start operations in 2025. TAZIZ Ruwais Complex profile includes core details such as complex name, location, complex status, start year, annual petrochemical capacity (mtpa) for the period 2015-2030, key...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – RSC-1255
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RSC-1255 Drug Details RSC-1255 is under development for the treatment of advanced solid tumor...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.